Dr. James D. Battiste
Claim this profileUniversity of Oklahoma Health Sciences Center
Studies Glioblastoma
Studies Brain Tumor
12 reported clinical trials
20 drugs studied
Area of expertise
1Glioblastoma
IDH negative
Stage IV
IDH positive
2Brain Tumor
Stage IV
SMO positive
PTCH1 positive
Affiliated Hospitals
Clinical Trials James D. Battiste is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting1 award Phase 210 criteria
Targeted Therapy
for Brain Cancer
This phase II trial studies how well genetic testing works in guiding treatment for patients with solid tumors that have spread to the brain. Several genes have been found to be altered or mutated in brain metastases such as NTRK, ROS1, CDK, PI3K, or KRAS G12C. Medications that target these genes such as abemaciclib, paxalisib, entrectinib and adagrasib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Genetic testing may help doctors tailor treatment for each mutation.
Recruiting1 award Phase 217 criteria
More about James D. Battiste
Clinical Trial Related1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments James D. Battiste has experience with
- Nivolumab
- Abemaciclib
- Temozolomide
- Radiation Therapy
- Ipilimumab
- DCVax®-L
Breakdown of trials James D. Battiste has run
Glioblastoma
Brain Tumor
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James D. Battiste specialize in?
James D. Battiste focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are Stage IV.
Is James D. Battiste currently recruiting for clinical trials?
Yes, James D. Battiste is currently recruiting for 3 clinical trials in Oklahoma City Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that James D. Battiste has studied deeply?
Yes, James D. Battiste has studied treatments such as Nivolumab, Abemaciclib, Temozolomide.
What is the best way to schedule an appointment with James D. Battiste?
Apply for one of the trials that James D. Battiste is conducting.
What is the office address of James D. Battiste?
The office of James D. Battiste is located at: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104 United States. This is the address for their practice at the University of Oklahoma Health Sciences Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.